or
forgot password
  • cancer clinical trials in rochester, MN

  • Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Carcinoma of Unknown Primary
    Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features
    Lycopene in Treating Patients With Metastatic Prostate Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Prostate Cancer
    Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Inflammatory Breast Cancer, Male Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Pemetrexed Disodium in Treating Young Patients With Recurrent Solid Tumors
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Unspecified Childhood Solid Tumor, Protocol Specific
    Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Unspecified Adult Solid Tumor, Protocol Specific
    A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)
    Pfizer Investigational Site
    Rochester, Minnesota 55905
    Gastrointestinal Stromal Tumor
    Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Gastrinoma, Glucagonoma, Insulinoma, Metastatic Gastrointestinal Carcinoid Tumor, Pancreatic Polypeptide Tumor, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell Carcinoma, Somatostatinoma, WDHA Syndrome
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Cancer Survivor, Sexual Dysfunction, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Multiple Myeloma, Plasma Cell Neoplasm
    Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas
    Mayo Clinic, Rochester
    Rochester, Minnesota 55905
    Neurofibromatosis 1, Neurofibroma, Plexiform
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors
    Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.
    Pfizer Investigational Site
    Rochester, Minnesota 55905
    Carcinoma, Renal Cell
    Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML)
    The Mayo Clinic
    Rochester, Minnesota 55905
    Acute Myeloid Leukemia
    Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
    Mayo Clinic Rochester
    Rochester, Minnesota 55905
    Liver Transplantation, Hepatitis, Cholestasis, Carcinoma, Hepatocellular
    Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Leukemia
    Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma
    Pfizer Investigational Site
    Rochester, Minnesota 55905
    Carcinoma, Renal Cell
    Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lung Cancer, Precancerous Condition
    Computed Tomographic Colonography in Screening Healthy Participants for Colorectal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Colorectal Cancer
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain Tumor, Central Nervous System Tumor
    Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Endometrial Cancer
    Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas
    Mayo Clinic
    Rochester, Minnesota 55905
    Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    A Study of ARRY-142886 in Patients With Advanced Cancer
    Mayo Clinic Rochester
    Rochester, Minnesota 55905
    Advanced Cancer
    Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor
    Mayo Clinic
    Rochester, Minnesota 55905
    Gastrointestinal Stromal Tumor, Recurrent Adult Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
    Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Unspecified Adult Solid Tumor, Protocol Specific
    Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Breast Cancer
    Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Rochester, Minnesota 55905
    Lung Neoplasms, Carcinoma, Non-small Cell Lung
    3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer
    Mayo Clinic
    Rochester, Minnesota 55905
    Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas
    Mayo Clinic
    Rochester, Minnesota 55905
    Adult Grade III Lymphomatoid Granulomatosis, AIDS-related Peripheral/Systemic Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific, Waldenström Macroglobulinemia
    Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer
    Sorafenib in Treating Patients With Metastatic Breast Cancer
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
    Mayo Clinic
    Rochester, Minnesota 55905
    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors
    Mayo Clinic
    Rochester, Minnesota 55905
    Unspecified Adult Solid Tumor, Protocol Specific
    Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    North Central Cancer Treatment Group
    Rochester, Minnesota 55905
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Everolimus in Treating Patients With Stage IV Melanoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Melanoma (Skin)
    Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Epratuzumab and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia
    Mayo Clinic
    Rochester, Minnesota 55905
    Recurrent Childhood Acute Lymphoblastic Leukemia
    Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    The Mayo Clinic
    Rochester, Minnesota 55905
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    Trial of rPA-102 Vaccine in Healthy Adult Volunteers
    Mayo Clinic College of Medicine
    Rochester, Minnesota 55905
    Anthrax
    Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors
    Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Esophageal Cancer
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Mesothelioma
    Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine.
    Pfizer Investigational Site
    Rochester, Minnesota 55905
    Colorectal Neoplasms
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients
    Mayo Clinic
    Rochester, Minnesota 55905
    Lymphoma, Non-Hodgkin
    Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
    Mayo Clinic
    Rochester, Minnesota 55905
    Multiple Myeloma
    Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
    Mayo Clinic Foundation
    Rochester, Minnesota 55905
    Vasculitis, Wegener's Granulomatosis, Microscopic Polyangiitis
    Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Lymphoma
    Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
    Mayo Clinic Cancer Center
    Rochester, Minnesota 55905
    Brain and Central Nervous System Tumors, Unspecified Childhood Solid Tumor, Protocol Specific